Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026.
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $156.21 with a market capitalization of $41.6B.
Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026. Insmed Incorporated operates in the Healthcare sector. The…

Roth Capital analysts initiated coverage on Insmed Incorporated (NASDAQ:INSM) with a Buy rating on January 23, 2026.
Insmed Incorporated operates in the Healthcare sector. The stock currently trades at $156.21 with a market capitalization of $41.6B.
Current market data
NASDAQ · INSM
$125.30
Down: -$4.11 · -3.18%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·